Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8.56M
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
25.7M
-
Shares change
-
+1.77M
-
Total reported value, excl. options
-
$360M
-
Value change
-
+$19.8M
-
Put/Call ratio
-
0.57
-
Number of buys
-
41
-
Number of sells
-
-35
-
Price
-
$14.00
Significant Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q2 2017
99 filings reported holding ATRA - Atara Biotherapeutics, Inc. - Common Stock as of Q2 2017.
Atara Biotherapeutics, Inc. - Common Stock (ATRA) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.7M shares
.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (5.36M shares), Redmile Group, LLC (2.73M shares), ArrowMark Colorado Holdings LLC (2.08M shares), BlackRock Inc. (1.92M shares), FMR LLC (1.91M shares), BRIDGER MANAGEMENT, LLC (1.52M shares), EAGLE ASSET MANAGEMENT INC (1.49M shares), RTW INVESTMENTS, LP (1.17M shares), MORGAN STANLEY (987K shares), and Neuberger Berman Group LLC (968K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.